NORTHERA (DROXIDOPA) CAPSULES

Live / Registered — Registered — Section 8 accepted (as of 12 Jun 2024)

What this means for you

Registered since 19 Sept 2017. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
86922769
Registration number
5291968
Mark type
Design + words
Filed
29 Feb 2016
Published for opposition
11 Oct 2016
Registered
19 Sept 2017
Attorney of record
Maren C. Perry

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations for the prevention and treatment of neurogenic orthostatic hypotension and for the prevention and treatment of low blood pressure; pharmaceutical preparations for the prevention and treatment of Parkinson's disease and disorder; pharmaceutical preparations for the prevention and treatment of dizziness and lightheadedness; all of the above-referenced goods containing in significant part DROXIDOPA

Owner

Prior registrations

Prosecution history

  • 12 Jun 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
  • 12 Jun 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
  • 11 Jun 2024 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
  • 22 Mar 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 22 Mar 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
  • 22 Mar 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
  • 14 Dec 2023 — POST REGISTRATION ACTION MAILED - SEC. 8
  • 14 Dec 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
  • 18 Sept 2023 — TEAS SECTION 8 RECEIVED
  • 19 Sept 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
  • 19 Sept 2017 — REGISTERED-PRINCIPAL REGISTER
  • 12 Aug 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
  • 11 Aug 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
  • 17 Jul 2017 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 17 Jul 2017 — CORRESPONDENCE RECEIVED IN LAW OFFICE

View this trademark record on Marksy